Drawing for POSSIBILITIES MADE REAL

USPTO serial 85908052

POSSIBILITIES MADE REAL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SOBRAL, CHRISTINA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with POSSIBILITIES MADE REAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Glenn A. Gundersen

GLENN A. GUNDERSEN DECHERT LLP2929 ARCH ST STE 400PHILADELPHIA, PA 19104-2808UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Economic forecasting and analysis for the health industry; business management and consulting services for the health industry in the field of marketing, research, and development; market research, namely, collecting market trends data from providers and patients, data on health economic issues, and competitive intelligence data on the marketplace for pharmaceutical products and medical devices; administering customer service programs, namely, operating patient assistance programs for pharmaceutical products and medical devices, and providing access to advocacy groups and counseling for patients to promote patient satisfactionACTIVE—
036Providing a database featuring information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devicesACTIVE—
042Testing and development of pharmaceuticals, biotechnology products, and medical devices; organizing and managing clinical trials for pharmaceuticals, biotechnology products, and medical devices for others; clinical research services, namely, collection, calibration, analysis, and reporting of data in connection with clinical trials of pharmaceutical, biotechnology products, and medical devices; consulting and support services in the field of clinical trials of pharmaceuticals, namely, forecasting drug supply requirements for clinical trials, monitoring drug supplies in clinical trials, and analyzing and reporting data related to the foregoingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 9, 2014MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 9, 2014ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 5, 2013NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 10, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 10, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 21, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 8, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 8, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 7, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 7, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 7, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 5, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 5, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 5, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 5, 2013DOCKASSIGNED TO EXAMINER—
May 9, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 9, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 1, 2013ALIEASSIGNED TO LIE—
Apr 26, 2013PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Apr 25, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 22, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance